This multi-stakeholder virtual event will feature expert faculty presenters at the forefront of clinical applications of bispecifics and T cell engagers and toxicity management. The webinar will highlight clinical insights in identifying immune-related adverse events (irAEs) associated with bispecifics and T cell engagers, primarily cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS), and best practices in irAE management. Topics to be addressed include irAEs associated with bispecifics and T cell engagers and multidisciplinary, collaborative approaches to prevent, recognize, and treat irAEs and improve patient outcomes.